期刊文献+

陷阱因子3在类风湿关节炎患者血清及外周血单核细胞中的表达研究 被引量:7

Expression of DcR3 in serum and PBMC derived from patients with rheumatoid arthritis
原文传递
导出
摘要 目的研究类风湿关节炎(RA)患者血清及外周血单核细胞中DcR3的表达情况。方法选取已确诊的60例类风湿因子(RF)(+)的RA患者并按照DAS28评分将其分为RAa组和RAb组,以30名体检健康者作为对照,酶联免疫吸附试验(ELISA)法检测各组血清可溶性陷阱因子3(DcR3)的表达情况。同时荧光实时定量聚合酶链反应(PCR)检测各组外周血单核细胞中DcR3的表达情况。采用t检验和,检验进行统计学分析。结果DcR3血清表达水平在DAS28〉2.6的RAb组为(264±72)ng/ml较健康对照组为(48±39)ng/ml明显升高(r=0.251,P〈0.05)。而在DAS28〈2.6的RAa组则没有差异。DcR3基因的扩增倍数在RAb组为23.5±5.4,健康对照组为8.3±3.6,差异具有统计学意义(r=0.336,P〈0.05)。结论DcR3在RA患者血清及外周血单核细胞中表达增高,而其血清表达水平在风湿活动较高的患者则更加明显。 Objective To study the decoy receptor 3 (DcR3) protein in the serum and its gene in PBMC from patients with rheumatoid arthritis (RA) and compared with healthy volunteers. Methods Sixty patients with rheumatoid arthritis whose RF were all positive, were grouped into RAa and RAb based on DSA28 scores. And 30 healthy volunteers were prepared. The expression of soluble DeR3 protein in the serum of RA patients and healthy volunteers was examined by enzyme-linked immunosorbent assay (ELISA). The expression of DcR3 gene in the PBMC of RA patients and healthy volunteers was examined by Real-time-PCR. Results The concentration of soluble DcR3 protein in serum of RAa group was (264±72) ng/ml and that of the control was (48±39) ng/ml. The expression of DcR3 in the sera of RA patients was significantly higher than that of healthy volunteers (r=0.251, P〈0.05). And a correlation between serum DcR3 concentration and the disease activities was seemed to be observed. The amplification altitude of the DcR3 gene of PBMC of RA group was 23.5±5.4 and the control was 8.3±3.6. The difference was significant (r=0.336, P〈0.05). Conclusion The DcR3 is highly expressed in patients with RA. And the seems DcR3 level is higher in patients with DAS28 grade 〉2.6 group.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2012年第1期47-49,共3页 Chinese Journal of Rheumatology
基金 湖北省卫生厅基金(NX2001-10)
关键词 关节炎 类风湿 DCR3 血清 单核细胞 Arthritis, rheumatoid DcR3 Serum Monocytes
  • 相关文献

参考文献1

二级参考文献9

  • 1Pitti RM, Marsters SA, Lawrence DA, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature,1998,396:699-703.
  • 2Bai C, Connolly B, Metzker ML, et al. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci USA, 2000,97:1230-1235.
  • 3Roth W, Isenmann S, Nakamura M, et al. Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligandinduced apoptosis and chemotaxis. Cancer Research, 2001,61:2759-2765.
  • 4Yu KY, Kwon B, Ni J, et al. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHTmediated apoptosis. J Biol Chem, 1999,274:13733-13736.
  • 5Ohshima K, Haraoka S, Sugihara M, et al. Amplification and expression of a decoy receptor for fas ligand ( DcR3 ) in virus ( EBV or HTLV-Ⅰ) associated lymphomas. Cancer Lett , 2000,160:89-97.
  • 6Otsuki T, Tomokuni A, Sakaguchi H, et al. Over-expression of the decoy receptor 3 ( DcR3 ) gene in peripheral blood mononuclear cells( PBMC ) derived from silicosis patients. Clin Exp Immunol, 2000,119:323-327.
  • 7Gelmini S, Orlando C, Sestini R, et al. Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure c-erbB-2 oncogene amplification. Clinical Chemistry, 1997,43:752-758.
  • 8Sinicrope FA, Ruan SB, Cleary KR, et al. Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res,1995,55:237-241.
  • 9Ibrahim SM, Ringel J, Schmidt C, et al. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death.Pancreas, 2001,23:72-79.

共引文献19

同被引文献68

  • 1李守新,刘雯,王晓慧,黄睿,雷小妹,刘晓城.系统性红斑狼疮外周血单个核细胞DcR3 mRNA表达研究[J].临床内科杂志,2007,24(3):168-170. 被引量:1
  • 2McInnes IB; Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol, 2007, 7: 429-442.
  • 3You RI, Chang YC, Chen PM, et al. Apoptosis ofdendfitic cells induced by decoy receptor 3 (DcR3). Blood, 2008, 111: 1480- 1488.
  • 4Cheng CP, Sytwu HK, Chang DM. Decoy receptor 3 attenuates collagen-induced arthritisby modulating T cell activation and B cell expansion. J Rheumatol, 2011, 38 : 2522-2535.
  • 5Britsemmer K, Ursum J, Gerritsen M. Validation of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: slight improvement over the 1987 ACR criteria. Ann Rheum Dis, 2011, 70: 1468-1470.
  • 6Bamias G, Martin C 3rd, Marini M, et al. Expression, localization, and functional activity of TL1A, a novel Thl-polarizing cytokine in inflammatory bowel disease. J Immunol, 2003, 171: 4868-4874.
  • 7Han B, Bojalil R, Amezcua-Guerra LM, et al. DcR3 as a diagnostic parameter and risk factor for systemic lupuserythematosus. Int Immunol, 2008, 20: 1067-1075.
  • 8Han B, Moore PA, Wu J, et al. Overexpression of human decoy receptor 3 in mice results in a systemic lupus erythe-matosus- like syndrome. Arthritis Rheum, 2007, 56: 3748-3758.
  • 9Meylan F, Davidson TS, Kahle E, et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity, 2008, 29: 79-89.
  • 10Wroblewski V J, Witcher DR, Becker GW, et al. Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragmenthaving differential activities against Fas ligand and LIGHT. Biochem Pharmacol, 2003, 65: 657-667.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部